
About Foundation for Advancement of Essential Diagnostics
Data last updated:
Foundation for Advancement of Essential Diagnostics is a private not for profit company based in Guwahati, Assam, India, recognised as a startup by DPIIT. It operates in the hospital and clinical services segment of the healthcare sector. It was incorporated on 19 November 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Guwahati, under CIN U73200AS2018NPL018870.
It is led by directors including Amaj Ahmed Laskar and Anamika Baruah.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at House Number 11 Latakata Road Maidamgaon Bakrapara Basistha, Guwahati, Assam, India – 781029.
As per the financials filed for FY 2025, the company reported a revenue of ₹42.84 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹17.71 Lakh (net margin 41.3%) and EBITDA of ₹18.06 Lakh (EBITDA margin 42.2%). Revenue has grown at a compounded annual rate (CAGR) of 60% over three years and 87% over five years.
The company is associated with 1 brand: FAED.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website faed.in.
Company details
Recognitions & Rankings of Foundation for Advancement of Essential Diagnostics
Contact details
Foundation for Advancement of Essential Diagnostics's registered office is in Guwahati, Assam. Its website is faed.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressHouse Number 11 Latakata Road Maidamgaon Bakrapara Basistha, Guwahati, Assam, India – 781029
- IndustryHealthcare, Hospitals
To see the full contact details of Foundation for Advancement of Essential Diagnostics, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Foundation for Advancement of Essential Diagnostics is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Foundation for Advancement of Essential Diagnostics, buy the company report.
Financials of Foundation for Advancement of Essential Diagnostics
FY 2025 filings availableFoundation for Advancement of Essential Diagnostics reported revenue of ₹42.84 Lakh (up 193% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 87% over five years, including 193% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹18.06 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹17.71 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 42.2% | ||||
| Net Profit Margin | 41.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Foundation for Advancement of Essential Diagnostics, buy the company report.
Board of directors of Foundation for Advancement of Essential Diagnostics
Foundation for Advancement of Essential Diagnostics has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Amaj Ahmed Laskar | Director | 19 Nov 2018 | 7 Years 11 Months | Current |
| Anamika Baruah Also directs: Apexmind Collective Private Limited | Director | 19 Nov 2018 | 7 Years 11 Months | Current |
| Mustafa Ahmed Barbhuiya Also directs: Negrove Agribusiness Private Limited | Director | 19 Nov 2018 | 7 Years 11 Months | Current |
Auditor
Foundation for Advancement of Essential Diagnostics is audited by SALIL AGARWAL & CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SALIL AGARWAL & CO | FY 2020 | 326763E |
Shareholding
The shareholding of Foundation for Advancement of Essential Diagnostics is on record for FY 2020, split between promoters, domestic institutions and public shareholders.
| Shareholder category | FY 2020 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public |
To see the full shareholding pattern of Foundation for Advancement of Essential Diagnostics, buy the company report.
Legal cases
No court or tribunal cases involving Foundation for Advancement of Essential Diagnostics are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Foundation for Advancement of Essential Diagnostics; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Foundation for Advancement of Essential Diagnostics; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Foundation for Advancement of Essential Diagnostics has 3 board changes on record since 2018: 3 appointments. The latest: Amaj Ahmed Laskar was appointed as Director on 19 Nov 2018.
Frequently asked questions
Foundation for Advancement of Essential Diagnostics is an active private not for profit company based in Guwahati, Assam, India. The company works in hospitals, within the healthcare industry. It was incorporated on 19 November 2018 (8+ years old) and is registered under CIN U73200AS2018NPL018870.
Foundation for Advancement of Essential Diagnostics has 3 current directors:
- Amaj Ahmed Laskar - Director
- Anamika Baruah - Director
- Mustafa Ahmed Barbhuiya - Director
The latest financial statements of Foundation for Advancement of Essential Diagnostics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The CIN (Corporate Identification Number) of Foundation for Advancement of Essential Diagnostics is U73200AS2018NPL018870. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Foundation for Advancement of Essential Diagnostics was incorporated on 19 November 2018, making it 8+ years old. It is registered with the Registrar of Companies, Guwahati.
Amaj Ahmed Laskar was appointed as Director on 19 Nov 2018. Anamika Baruah was appointed as Director on 19 Nov 2018. Mustafa Ahmed Barbhuiya was appointed as Director on 19 Nov 2018.
Yes, Foundation for Advancement of Essential Diagnostics is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Foundation for Advancement of Essential Diagnostics can be reached through the website faed.in. Its registered office is in Guwahati, Assam, India.
The registered office of Foundation for Advancement of Essential Diagnostics is at House Number 11 Latakata Road Maidamgaon Bakrapara Basistha, Guwahati, Assam, India – 781029.
Foundation for Advancement of Essential Diagnostics operates in the healthcare industry, in the hospitals segment.

